Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China flag China · Delayed Price · Currency is CNY
13.89
-0.18 (-1.28%)
Apr 9, 2026, 11:30 AM CST
Market Cap7.97B -3.1%
Revenue (ttm)3.13B -30.0%
Net Income281.38M -33.8%
EPS0.49 -33.7%
Shares Out566.16M
PE Ratio28.67
Forward PE19.82
Dividendn/a
Ex-Dividend Daten/a
Volume5,621,600
Average Volume5,924,145
Open13.95
Previous Close14.07
Day's Range13.88 - 14.33
52-Week Range11.95 - 20.20
Beta0.60
RSI48.71
Earnings DateApr 23, 2026

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1975
Employees 6,132
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600557
Full Company Profile

Financial Performance

In 2024, SHA:600557's revenue was 3.90 billion, a decrease of -19.86% compared to the previous year's 4.86 billion. Earnings were 391.86 million, a decrease of -15.58%.

Financial Statements